Näytetään tulokset 1 - 3 / 3
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone:A pooled analysis

Vertaisarvioitu
DOI
10.1111/ejh.12903
Moreau, Philippe; Dimopoulos, Meletios A.; Richardson, Paul G.; Siegel, David S.; Cavo, Michele; Cor...
European journal of haematology2017

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010):a phase 3b study in refractory multiple myeloma

Vertaisarvioitu
DOI
10.1182/blood-2016-02-700872
Dimopoulos, Meletios A.; Palumbo, Antonio; Corradini, Paolo; Cavo, Michele; Delforge, Michel; Di Rai...
Blood2016

Health-related quality-of-life results from the phase 3 OPTIMISMM study:pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2020.1747066
Weisel, Katja; Dimopoulos, Meletios; Moreau, Philippe; Yagci, Munci; Larocca, Alessandra; Kanate, Ab...
Leukemia & lymphoma2020

Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone:A pooled analysis

Vertaisarvioitu
DOI
10.1111/ejh.12903
2017

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010):a phase 3b study in refractory multiple myeloma

Vertaisarvioitu
DOI
10.1182/blood-2016-02-700872
2016

Health-related quality-of-life results from the phase 3 OPTIMISMM study:pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2020.1747066
2020